UroToday.com (@urotoday) 's Twitter Profile
UroToday.com

@urotoday

Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology

ID: 21319494

calendar_today19-02-2009 17:36:50

118,118K Tweet

28,28K Takipçi

6,6K Takip Edilen

UroToday.com (@urotoday) 's Twitter Profile Photo
UroToday.com
@urotoday

5 days ago

Mevrometostat in combination with enzalutamide in patients with #mCRPC previously treated with abiraterone acetate: The phase 3, randomized #MEVPRO-1 study. Presentation by Neeraj Agarwal, MD, FASCO Huntsman Cancer Institute. #ASCO25 written coverage by Julian Chavarriaga University of Toronto > bit.ly/3SyaeZi

Mevrometostat in combination with enzalutamide in patients with #mCRPC previously treated with abiraterone acetate: The phase 3, randomized #MEVPRO-1 study. Presentation by <a href="/neerajaiims/">Neeraj Agarwal, MD, FASCO</a> <a href="/huntsmancancer/">Huntsman Cancer Institute</a>. #ASCO25 written coverage by <a href="/chavarriagaj/">Julian Chavarriaga</a> <a href="/UofT/">University of Toronto</a> &gt; bit.ly/3SyaeZi